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 Abstract
Cryosurgery is a destructive technique that was introduced to gynecology in the late 1960s to treat CIN (cervical 
intraepithelial neoplasia). Tens of thousands of patients have been treated with cryotherapy, which has proved to 
be a predictable, reliable treatment technique, with limited side effects and morbidity. This method is used to treat 
cervical, vaginal, endometrial and vulvar lesions. 
This study aims at determining the current state of knowledge on the place of cryosurgery (cryotherapy) in 
gynecological practice. Research was carried out to find current data on indications, contraindications, techniques 
of treatment and equipment necessary to perform cryosurgical procedures in gynecology. 
Cryosurgery is a safe, relatively inexpensive and easy to perform procedure for treating women with lower genital 
tract pre-malignant diseases without impairing their fertility. 
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 Streszczenie
Kriochirurgia jest ablacyjną metodą leczenia wprowadzoną do praktyki ginekologicznej pod koniec lat 60-tych 
ubiegłego stulecia, początkowo tylko do leczenia śródnabłonkowej neoplazji szyjki macicy. Od tego czasu zakres 
wskazań dla tego typu terapii uległ znacznemu poszerzeniu i do chwili obecnej na całym świecie wykonano tysiące 
zabiegów kriochirurgii ze wskazań ginekologicznych. 
Celem pracy jest przedstawienie aktualnego stanu wiedzy na temat tej metody terapeutycznej oraz określenie jej 
miejsca w nowoczesnej praktyce ginekologicznej.
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Introduction
Cryosurgery	is	a	destructive	technique	that	was	introduced	to	
gynecology	in	the	late	1960s	to	treat	CIN	(cervical	intraepithelial	
neoplasia).	 Tens	 of	 thousands	 of	 patients	 have	 been	 treated	
with	cryotherapy,	which	has	proved	to	be	a	predictable,	reliable	
treatment	technique	with	limited	side	effects	and	morbidity	[1].	
History
Therapeutic	use	of	cold	temperature	has	existed	for	a	 long	
time	in	the	medical	setting,	first	and	foremost	for	its	anaesthetizing	
effects.	But	the	damage	that	cold	can	do	has	also	been	noted	from	
the	 earliest	 times	 and	has	been	mentioned	 in	both	 civilian	 and	
military	sources,	including	historical	accounts	discussing	the	effect	
of	cold	climates	on	various	body	tissues	[2].	The	first	successful	
treatments	 of	 malignant	 diseases	 using	 cold	 were	 reported	 in	
England	between	1845	and	1851	by	James	Arnott	(1797-1883),	
who	used	iced	saline	solutions	at	temperatures	of	-180C	to	-240C	
to	treat	advanced	breast	and	uterine	cancer	[3].	Cryosurgery	was	
first	reported	to	be	used	in	the	therapy	of	cervical	intraepithelial	
neoplasia	(CIN)	by	Crisp	[4].	It	was	quickly	adopted	as	the	major	
form	 of	 therapy	 for	 cervical	 intraepithelial	 neoplasia	 lesions	
(CIN)	after	appropriate	diagnosis.	Two	decades	later,	Benedet	and	
associates	also	reported	excellent	results	in	cryosurgery	for	CIN	3	
lesions	with	a	failure	rate	of	only	5,5%	[5].	Similarly,	Collins	and	
colleagues	 [6]	 and	Ostergard	 and	 associates,	 used	 cryosurgical	
techniques	in	patients	with	gynecologic	inflammatory	diseases	to	
treat	chronic	cervicitis	[7].	
Historically,	the	use	of	cryoablation	to	treat	the	endometrium	
was	 first	 described	 in	 1967	 by	 Cahan	 and	 Brockunier	 [8].	
Droegemueller	performed	a	series	of	cases	in	the	early	1970s	[9]	
and	Pitroff	treated	67	women	in	the	early	1990s	[10].	A	decade	
later,	 CryoGen	 Inc	 developed	 the	 Her	 Option®	 Cryoablation	
Therapy	System	which	was	 approved	by	FDA	 for	 endometrial	
ablation	in	April	2001.
Principles of cryosurgery
Cryosurgery	 involves	 cooling	 the	 tissue	 until	 cryonecrosis	
occurs.	 An	 important	 principle	 of	 physics	 is	 that	 the	 heat	 is	
transferred	between	entities,	as	opposed	to	cold	being	added	to	
an	entity.	During	the	cryotherapy	of	the	cervix,	heat	is	removed	
from	the	cervix	to	the	cryoprobe	tip	at	a	rate	faster	than	heat	can	
be	delivered	to	the	cervix	through	blood	flow	from	the	cervical	
branches	of	uterine	arteries.	Hypothermia	is	achieved	by	passing	
compressed	 refrigerant	 gas	 (carbon	 dioxide	 or	 nitrous	 oxide)	
through	a	small	orifice	at	the	tip	of		cryoprobe,	the	Joule	Thomson	
effect.	Temperatures	 of	 less	 than	 -20°C	 are	 required	 for	 tissue	
necrosis	[11].	During	cryotherapy	freezing	of	tissue	appears	after	
formation	of	an	iceball.	The	cellular	membranes	are	pierced	by	
the	ice	crystals	that	form,	releasing	the	intracellular	contents	and	
causing	vascular	thrombosis	and	microcirculatory	failure	anoxia	
and	ischemia	[12].	A	double	freeze	(freeze-thaw-freeze)	treatment	
is	more	effective	than	a	single-freeze	procedure	[13].
A	 method	 of	 rapid	 freeze	 and	 a	 slow	 defrost	 is	 the	 most	
effective	 method	 of	 inducing	 tissue	 damage.	 The	 temperature	
of	cryoprobe	tip,	using	a	nitrous	oxide	system,	is	approximately	
-65	 to	 -75°C	 during	 cryotherapy.	 The	 temperature	 at	 the	 edge	
of	 the	 frozen	 tissue	will	be	 around	 -20°C.	The	mean	probe	 tip	
temperature	should	be	-60°C	[14].	
During	cryotherapy	two	clinically	relevant	temperature	zones	
are	produced	within	the	iceball.	The	lethal	zone	is	the	frozen	area	
located	between	the	cryoprobe	tip	and	-200C	isotherm.	Tissues	in	
this	area	will	not	survive	the	freeze.	The	more	peripherally	located	
zone	is	represented	by	frozen	tissue	with	temperatures	between	
-20°C	and	0°C.	Tissue	in	the	recovery	zone	is	temporarily	frozen	
during	the	procedure	but	will	remain	viable	after	defrosting.	The	
recovery	 zone	 generated	 by	most	 cryosurgical	 units	 represents	
the	 most	 peripheral	 2mm	 rim	 of	 frozen	 tissue	 adjoining	 the	
leading	margin	of	 the	 iceball	 [15].	The	direct	 thermal	effect	of	
cryotherapy	 determines	 eventual	 treatment	 success.	 Neoplasia	
within	 the	 lethal	 zone	 is	 readily	 destroyed	 by	 cryonecrosis.	
However,	 adjoining	 tissue	 temporarily	 frozen	 in	 the	 recovery	
zone	and	more	peripherally	positioned	non-frozen	residual	minor	
neoplasia	may	regress	following	cryotherapy	through	the	actions	
of	 the	 immune	 system.	After	 cryotherapy	 a	 large	 central	 viral	
(HPV)	 load	 is	debulked	and	 the	 immune	system	may	be	better	
able	 to	 eradicate	 a	 limited	 amount	 of	 surrounding	 low-grade	
residual	disease	[16].
Equipment 
Cryosurgery	 can	 be	 performed	 using	 carbon	 dioxide	 or	
nitrogen	 oxide	 as	 the	 coolant.	 Carbon	 dioxide	 is	 cheaper	 than	
nitrous	 oxide	 but	 the	 temperature	 achieved	by	nitrous	 oxide	 is	
lower	 than	 that	 obtained	 by	 carbon	 dioxide.	 Hence,	 the	 depth	
of	 tissue	 destruction	 is	 greater	with	 nitrous	 oxide	 and	 it	 is	 the	
preferred	coolant	[17].	The	equipment	needed	for	cryosurgery	of	
the	cervix	is	listed	in	table	I.	
Nitrous	oxide	tanks	with	a	pressure	gauge	should	have	high-
strength	gas	lines	pretested	2000	PSJ.	This	will	allow	for	a	faster	
and	more	 effective	 freeze.	 It	 is	 also	 important	 to	 have	 several	
cryoprobe	tips	available	to	choose	from,	including	an	assortment	
of	shapes	and	sizes.	This	will	allow	the	clinician	to	choose	the	
appropriate	size	and	maximize	the	chances	of	cure	success	[18].	
The	choice	of	a	cryoprobe	to	be	used	depends	on	the	size	of	the	
lesion	and	the	morphology	of	the	transformation	zone.	Use	of	a	
flat	cryoprobe	or	one	with	a	small	central	nipple	diminishes	the	
possibility	of	cervical	 stenosis.	This	 type	of	probe	will	 also	be	
less	likely	to	cause	the	squamous	cellular	junction	to	recess	into	
the	endocervical	canal,	resulting	in	an	unsatisfactory	colposcopy	
in	 following	examination	 [19].	The	best	option	 for	 the	 sake	of	
maximizing	patient	cure	is	to	use	a	nipple-shaped	probe	tip	with	
no	more	than	a	5-mm	nipple	extension	for	most	initial	freezes.
Table I. The equipment needed for cryosurgery (cryotherapy) [18]. 
The equipment required for cryosurgery
Cryogun•	
Large nitrous oxide tank with a pressure gauge and at least •	
20 psi of pressure in the tank
Various sizes and shapes of cryotips•	
Water-soluble lubricating gel•	
Vaginal speculum•	
Colposcope•	
3 to 5% acetic acid or vinegar•	
Vaginal wall retractors•	
Disinfectant for cryoprobes•	
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Indications for cryosurgery
Cryosurgery	is	a	technique	used	for	treating	cervical,	vaginal,	
endometrial	 and	vulvar	 lesions.	This	method	 is	mainly	used	 to	
treat	cervical	changes.	The	main	 indications	for	cryosurgery	of	
cervical	lesions	can	be	divided	into	two	groups:	benign	indications	
and	premalignant	indications.	The	benign	group	of	indications	for	
cervical	 cryosurgery	 includes:	 recurrent	 cervicitis	 and	 cervical	
erosion	(ectropion).	If	women	are	to	receive	cryosurgery	due	to	
such	benign	indications,	the	cytologic	and	colposcopic	assessment	
is	essential	prior	to	the	procedure	to	exclude	significant	neoplasia.	
Normal	Papanicolaou	(Pap)	smear	is	not	sufficiently	sensitive	to	
guarantee	 normality.	 The	 premalignant	 indication	 for	 cervical	
cryotherapy	 is	a	biopsy-confirmed	premalignant	cervical	 lesion	
(CIN1-CIN3).	It	is	probably	best	reserved	for	small	sizes	lesions	
and	LSIL	(low	grade	squamous	intraepithelial	lesions)	[16].
Cryosurgery of CIN
The	 International	Agency	 for	Research	on	Cancer	 (IARC)	
states	that	cryosurgery	(cryotherapy)	can	be	used	in	the	treatment	
for	CIN	provided	that:	
the	 lesion	 is	 in	 the	 ectocervix	without	 extension	 to	 the		
vagina	and/or	endocervix
the	 lesion	 is	 entirely	 visible	 and	 does	 not	 extend	more		
than	2-3	mm	into	the	cervical	canal
there	 is	 no	 evidence	 of	 invasive	 cancer	 or	 glandular		
involvement	and	the	endocervix	is	normal
the	lesion	can	be	adequately	covered	by	largest	available		
cryoprobe	tip	of	25	mm	diameter	[13]
The	American	Society	for	Colposcopy	and	Cervical	Pathology	
(ASCCP)	in	2006	ASCCP	guidelines	stated	that	ablative	therapy	
is	acceptable	provided	that:
colposcopy	 is	 satisfactory,	 the	 endocervical	 curettings		
are	negative	for	CIN	and	cancer	and	it	is	not	a	recurrent	
lesion	following	prior	therapy	[20]
cryotherapy	 is	 used,	 in	 cases	 of	 advanced	 stages	 of		
cervical	 cancer,	 to	 control	 the	 bleeding	 while	 awaiting	
conventional	therapy	[21]
The	Polish	Gynecologic	Society	Recommendations	in	2009	
state	 that	 performing	 cryosurgery	 of	 	 CIN	 is	 acceptable	 under	
the	strictly	outlined	conditions	that	allow	performing	this	type	of	
procedures	safely	[22].	
The	cryosurgery	of	CIN	is	not	recommended	by	the	National	
Health	 Service	 Practice	 Guidelines	 	 due	 to	 higher	 failure	 rate	
[23].		
Benedet	et	al.	determined	parameters	 that	are	necessary	 to	
increase	success	rates	in	the	treatment	of	CIN	[24]:
minimal	 endocervical	 extension	 of	 the	 transformation		
zone	
fully	visible	lesion	margins	
excellent	probe	–	epithelium	contact	
satisfactory	iceball	formation	extending	3-4	mm	beyond		
the	lesion	margins
adequate	cryotherapy	gas	pressure		
Cryosurgery	 is	 a	 safe,	 useful,	 inexpensive	 procedure	 that	
should	 be	 considered	 for	 any	 patient	 (particularly	 young	 and	
nulliparous)	with	CIN	1	or	2,	confined	to	one	or	two	quadrants	of	
the	exocervix	[1].
Cryosurgery of the vagina
Cryotherapy	of	vaginal	 lesions	 is	not	 a	popular	method	 in	
treating	 vaginal	 intraepithelial	 neoplasia	 (VAIN).	 However,	
Townsend	has	reported	treatment	of	VAIN	by	cryosurgery	[25].	
Due	to	possible	post-therapeutic	complications,	he	recommends	
a	 single	 freeze-thaw	cycle	with	 the	 iceball	 extending	 to	 3	mm	
of	 colposcopically	 normal	 epithelium.	 Detailed	 colposcopical	
assessment	 is	 required	 for	 the	 management	 of	 such	 vaginal	
lesions.	If	the	lesion	cannot	be	covered	by	the	probe	tip,	it	should	
be	subdivide	for	individual	freezing	with	the	iceballs	overlapping.	
Effectiveness	and	 safety	of	 the	cryosurgery	 in	 the	 treatment	of	
VAIN	has	not	been	estimated.
Cryosurgery of the vulva
Vulvar	lesions	can	be	treated	by	cryotherapy.	Townsend	states	
that	VIN	(vulvar	intraepithelial	lesion)	lesion	less	than	2	cm	in	
diameter	can	be	treated	by	cryosurgery.	He	recommends	nitrous	
oxide,	a	single	freeze-thaw	cycle	and	extension	of	iceball	at	least	
3	mm	on	to	colposcopically	normal	epithelium	[26].	Biopsy	of	the	
lesion	and	colposcopic	assessment	are	the	necessary	elements	of	
the	management	process.	Nevertheless,	CO2	laser	and	ultrasonic	
surgical	 aspirator	 are	 currently	most	 popular	 in	VIN	 treatment	
[17].	
Cryosurgery	can	be	used	as	a	palliative	 therapy	 in	case	of	
recurrent	fungating	cancer	of	vulva	and	perineum.	In	these	cases	
cryotherapy	 can	 be	 also	 used	 to	 decrease	 bleeding,	malodours	
discharge	and	patient	discomfort	[26].
Cryotherapy	has	been	used	on	the	vulva	to	eradicate	small	
warts.	The	freezing	 induces	 localized	 tissue	necrosis.	Although	
healing	 usually	 is	 satisfactory	 and	 numbing	 effects	 induce	
analgesia,	application	is	limited	by	the	delivery	system	and	probe	
tip	sizes.	Larger	condylomatous	masses	are	more	difficult	to	treat	
by	cryotherapy	and	 in	 such	cases	excisional	methods	are	more	
preferable	[27].
Cryosurgery	 has	 also	 been	 used	 to	 treat	 urethral	 prolapse.	
The	method	is	extremely	effective	in	producing	complete	annular	
necrosis	and	healing	of	the	prolapsed	tissue.	This	procedure	can	
be	performed	without	anesthesia	[28].
Cryoablatio endometrii
Cryoablatio	 endometrii	 is	 a	 cryosurgical	 technique	 for	
endometrial	destruction.	The	uterine	cryoablation	therapy	system	
consists	of	 a	5,5mm	cryoprobe	 that	 is	 inserted	 into	 the	uterine	
cavity.	 Transabdominal	 sonography	 is	 used	 to	 confirm	 proper	
placement	of	 the	probe	and	 to	follow	the	growth	of	 the	 iceball	
that	forms	during	the	treatment	cycle.	Once	activated,	the	system	
circulates	a	mixed	fluid	through	the	probe	to	achieve	intrauterine	
temperatures	between	-90°C	and	-110°C.	The	device	is	directed	
into	 the	 cornual	 regions,	 each	of	which	 is	 treated	 individually.	
Cryoablation	 of	 the	 endometrium	 is	 an	 effective	 therapeutic	
option	 for	 the	 management	 of	 menorrhagia.	 Later	 definitive	
surgery	may	be	required	in	6%	to	20%	of	women	after	endometrial	
cryoablation	[29].	
In	 the	 pilot	 study	 authors	 used	 the	 cryoablation	 of	 the	
endometrium	 in	 10	 women	 with	 menorrhagia	 and	 obtained	
high	therapeutic	efficacy	of	 this	method.	The	advantage	of	 this	
therapeutic	method	is	 the	simplicity	of	 its	 implementation,	 low	
cost	and	safety	[30].
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Contraindications for cryosurgery
In	gynecology	cryosurgery	is	mainly	used	in	therapy	of	the	
cervical	 lesions.	 The	 contraindications	 to	 cryotherapy	 of	 the	
cervix	include	(table	II):	
(a)	 presence	 of	 vulvitis,	 vaginitis,	 cervicitis	 and/or	 pelvic	
inflammatory	 disease.	 The	 following	 should	 be	 adequately	
treated	 before	 performing	 cryosurgery	 [17],	 (b)	 cervical	
cancer,	 (c)	 pregnancy,	 (d)	 in-utero	 DES	 exposure	 because	 of	
an	 increased	 risk	 for	 cervical	 stenosis,	 (e)	 menstruation,	 (f)	
unsatisfactory	 colposcopy,	 (g)	 positive	 endocervical	 curettage,	
(h)	 persistent	 CIN	 after	 previous	 cryotherapy,	 (i)	 high-grade	
CIN,	 (j)	 lesions	 larger	 than	 two	 cervical	 quadrants	 in	 size,	 (k)	
lesions	 greater	 than	 3	 cm	 in	 diameter,	 (l)	 lesions	 that	 extend	
more	 than	 5	mm	 into	 the	 endocervical	 canal,	 (m)	 lesions	with	
irregular	surface	(exophytic,	nodular	or	papillary)	or	obstetrical	
scars	 that	hinder	proper	application	of	 the	cryoprobe	 tip	 to	 the	
cervical	 transformation	zone	[16],	 (n)	 low	grade	CIN	preceded	
by	 a	 cytology	 report	 of	 HSIL	 (high	 squamous	 intraepithelial	
lesion)		or	AGC-NOS	(Atypical	Glandular	Cells	Not	Otherwise	
Specified),	i.e.	discordance	between	review	cytology,	colposcopy	
and	histopathology.	In	such	circumstances	a	diagnostic	excisional	
procedure	 is	 recommended	 [31],	 (o)	 a	woman	 presenting	with	
menstrual	 problems	 (especially	 intramenstrual	 bleeding)	 and	 a	
cervical	 ectropion.	Endometrial	 disease	 has	 to	 be	 ruled	 out	 by	
endometrial	biopsy	before	performing	cryosurgery	[16].
Complications	of	cryosurgery	and	side	effects	of	treatment
Cryosurgery	 is	 the	 most	 acceptable	 of	 all	 the	 ablative	
techniques	performed	in	gynecology.	Cryotherapy	of	the	cervix	
is	usually	accompanied	by	pain	and	cramping	of	varying	degrees	
[32].	 About	 20%	 of	 patients	 after	 cryosurgery	 of	 the	 cervix	
experience	 a	 profuse	 watery	 discharge	 for	 2	 to	 3	 weeks	 after	
cryotherapy	and	some	patients		experience	light	spotting	lasting	
for	about	two	weeks.	Late	complications	of	cryosurgery	are	rare	
and	consist	principally	of	cervical	stenosis	in	1	to	4%	of	patients	
[1].	Serious	complications	related	to	cryotherapy	are	rare.	Possible	
complications	include	vasovagal	episodes,	infection,	mucometria	
and	 bleeding.	 There	 is	 no	 evidence	 that	 cryotherapy	 has	 any	
adverse	 impact	 on	 fertility	 or	 pregnancy	 outcome	 [33].	 After	
the	 cryotherapy	 treatment	 	 the	 cervix	heals	well	 and	 there	 is	 a	
characteristic	appearance	of	radial	ridging.	The	squamocolumnar	
junction	(SCJ)	is	often	found	to	be	lying	just	within	the	external	
os.	But	in	many	patients	cervical	anatomy	has	been	changed	after	
cryosurgery	and	the	SCJ	may	not	be	visible	because	of	moving	
into	cervical	canal	[34].		
Results of treatment
Although	patient	 acceptability	 is	very	high,	 cryosurgery	 is	
becoming	 less	 popular,	 largely	 as	 a	 result	 of	 published	 results	
indicating	higher	failure	rates.	Cryotherapy	has	a	lower	clearance	
rate	 than	 other	 conservative	 techniques.	 Some	 authors	 have	
claimed	clearance	rates	of	about	95%	[35].	However,	the	general	
experience	appears	 to	be	 that	a	 rate	of	85%	is	more	frequently	
seen	 [36].	Average	cure	 rates	 in	 relation	 to	severity	of	cervical	
dysplasia	have	been	reported,	94%	cure	rate	for	CIN1,	93%	for	
CIN2,	and	84%	for	CIN3/CIS	[37].	Like	other	local	destructive	
methods,	the	size	of	the	lesion	and	not	the	biologic	stage	of	the	
CIN	seems	to	influence	the	chances	of	success	and	of	complete	
clearance.	Although	a	long-term	analysis	of	2839	patients	treated	
by	cryotherapy	demonstrated	a	negligible	risk	for	residual	disease	
[38],	 cervical	 cancer	 has	 been	 reported	 in	 women	 following	
cryotherapy	of	CIN	[39].	
At	 present	 cryosurgery	 of	 the	 cervix	 has	 lost	 ground	 to	
loop	 excisional	 procedures	 (LLETZ/LEEP),	which	 can	 also	 be	
performed	on	an	outpatient	basis	and	provide	a	good	specimen	
for	histology	[40].
Conclusions
In	 the	 past	 cervical	 neoplasia	 was	 managed	 primarily	 by	
excisional	surgery:	either	cold-knife	conization	or	hysterectomy.	
These	surgical	approaches	conveyed	a	small	but	significant	risk	of	
inadvertent	serious	harm	and	morbidity.	A	profound	reduction	of	
surgical	complications	was	noted	following	the	implementation	
of	cryotherapy	to	tread	premalignant	cervical	diseases	[16].	
Modern	 cryosurgery	 achieves	 efficiency	 and	 effectiveness	
through	good,	uncomplicated	 surgical	 results,	 a	high	cure	 rate,	
and	 a	 high	 quality	 of	 life	 for	 patients.	 The	 “power	 of	 cold”	
needs	to	be	understood	and	accepted	by	both	surgeons	and	other	
therapists	[41].	
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Table I. Contraindication for the cryosurgery of the cervix. 
Contraindication for the cryotherapy of the cervix
presence of vulvitis, vaginitis, cervicitis and or pelvic •	
inflammatory disease
cervical cancer•	
in-utero DES exposure •	
menstruation•	
unsatisfactory colposcopy•	
positive endocervical curettage•	
persistent CIN after previous cryotherapy•	
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